Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2677

Actual shortage: 256 (10%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2412 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

24 (9%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-DILTIAZEM CD 120MG CAPSULE (EXTENDED RELEASE) Resolved 2020-04-02 2020-04-16 110682
TEVA-DILTIAZEM CD 180MG CAPSULE (EXTENDED RELEASE) Resolved 2020-04-02 2020-05-14 110685
TEVA-DILTIAZEM CD 180MG CAPSULE (EXTENDED RELEASE) Resolved 2020-12-03 2020-12-03 129512
TEVA-DILTIAZEM CD 180MG CAPSULE (EXTENDED RELEASE) Resolved 2021-02-05 2021-03-04 133441
TEVA-DILTIAZEM CD 240MG CAPSULE (EXTENDED RELEASE) Resolved 2021-05-27 2021-07-09 140039
TEVA-DILTIAZEM CD 240MG CAPSULE (EXTENDED RELEASE) Resolved 2021-06-03 2021-06-10 140372
TEVA-DILTIAZEM XC 180MG TABLET (EXTENDED-RELEASE) Resolved 2023-02-16 2023-04-28 184919
TEVA-DILTIAZEM XC 240MG TABLET (EXTENDED-RELEASE) Resolved 2023-02-16 2023-04-28 184922
TEVA-DILTIAZEM XC 300MG TABLET (EXTENDED-RELEASE) Resolved 2023-02-16 2023-04-28 184925
TEVA-DILTIAZEM XC 360MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-08 2024-01-08 194191
TEVA-DILTIAZEM XC 360MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-20 2023-07-05 195763
TEVA-DILTIAZEM XC 240MG TABLET (EXTENDED-RELEASE) Resolved 2023-07-19 2023-12-14 199199
TEVA-DILTIAZEM XC 300MG TABLET (EXTENDED-RELEASE) Resolved 2023-07-21 2024-01-11 199717
TEVA-DILTIAZEM XC 180MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-12 2023-12-07 206904
TEVA-DILTIAZEM XC 240MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-11 2024-05-09 215740
TEVA-DILTIAZEM XC 300MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-18 2024-05-09 216466
TEVA-DILTIAZEM XC 360MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-07 2024-05-09 221546
TEVA-DOMPERIDONE 10MG TABLET Resolved 2020-09-11 2020-12-17 124104
TEVA-DOMPERIDONE 10MG TABLET Resolved 2023-02-09 2023-06-09 184183
TEVA-DOMPERIDONE 10MG TABLET Resolved 2023-10-19 2023-11-30 207506

Showing 1101 to 1120 of 2677

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
EPIRUBICIN FOR INJECTION 2MG SOLUTION Discontinued 2020-10-22 2020-10-24 126906
EPTIFIBATIDE INJECTION 0.75MG SOLUTION Discontinued 2017-06-27 2017-06-27 14024
EPTIFIBATIDE INJECTION 2MG SOLUTION Discontinued 2017-06-27 2017-06-27 14027
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
GEMCITABINE FOR INJECTION 1G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14033
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63967
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63970
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81337
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344
HYDROCORTISONE SODIUM SUCCINATE INJECTION Discontinued 2019-04-11 2019-04-11 81347
LEUCOVORIN CALCIUM INJECTION 10MG SOLUTION Discontinued 2017-06-27 2017-06-27 14036
LINEZOLID INJECTION Discontinued 2020-02-13 2020-02-13 106173
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION 40MG POWDER FOR SOLUTION Discontinued 2021-09-23 2021-09-23 146061
NOVAMOXIN 500MG CAPSULE Discontinued 2017-06-27 2017-06-27 14046
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81316
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-04-11 2019-04-11 81321
NOVAMOXIN 25MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81393

Showing 61 to 80 of 250